Clinical Trials Search | Clareo Health

Showing 1-2 of 2 trials

Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant

NCT06821256

This is a double-blind, randomized, sham-controlled clinical trial that aim to verify the safety and the efficacy of anodal transcranial direct current stimulation (tDCS) cerebellar symptoms in Multiple System Atrophy type C (MSA).

Multiple System Atrophy - Cerebellar Subtype (MSA-C)

University of Salerno30 participantsStarted Jul 2023

Salerno, Sa, Italy

UNKNOWN

Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy

NCT06890377

The aim of this study was to apply the targeted α-synuclein PET study technique to investigate the pathological load and spatial distribution characteristics of α-syn in MSA patients, and to assess its value as a biomarker for diagnostic typing, disease severity, and prognosis in MSA.

Multiple System Atrophy - Cerebellar Subtype (MSA-C)Multiple System Atrophy - Parkinsonian Subtype (MSA-P)

Min Zhao,MD90 participantsStarted Sep 2024

Hunan, Changsha, China

Data from ClinicalTrials.govTerms

Filters

Filters

Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant

Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy

Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant

Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy